Prostate cancer: open trials in Thailand

• NCT06136624

  Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Chulalongkorn University ( Site 1530), Bangkok · Faculty of Medicine Siriraj Hospital ( Site 1531), Bangkoknoi · Songklanagarind hospital ( Site 1527), Hat Yai · Faculty of Medicine - Khon Kaen University ( Site 1526), Muang

  Registry updated 2026-11-05

• NCT06925737

  A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Faculty of Medicine Siriraj Hospital ( Site 0885), Bangkoknoi · Bangkok Metropolitan Administration Medical College and Vajira Hospital ( Site 0887), Dusit

  Registry updated 2026-10-30

• NCT06136650

  A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Faculty of Medicine Siriraj Hospital ( Site 1356), Bangkoknoi · Songklanagarind hospital ( Site 1352), Hat Yai · Faculty of Medicine - Khon Kaen University ( Site 1351), Muang · Maharaj Nakorn Chiang Mai Hospital ( Site 1353), Muang · Chulalongkorn University ( Site 1355), Pathumwan

  Registry updated 2026-10-20

• NCT07611110

  AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

  Trial Treatment · Phase 3 · AstraZeneca

  Bangkok

  Registry updated 2026-10-19

• NCT07711002

  Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)

  Trial Treatment · Phase 3 · AstraZeneca

  Bangkok · Khlong Luang · Songkhla

  Registry updated 2026-10-15

• NCT06952803

  A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

  Trial Treatment · Phase 3 · AstraZeneca

  Bangkok · Khon Kaen · Muang · Pathum Thani · Songkhla

  Registry updated 2026-10-14

All Prostate cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error